Saturday, October 22 , 2016, 10:19 am | Fog/Mist 60º

  • Follow Noozhawk on LinkedIn
  • Follow Noozhawk on Pinterest
  • Follow Noozhawk on YouTube


MIT Enterprise Forum to Present ‘Sientra: The Newest Success Story in Santa Barbara’

The MIT Enterprise Forum Central Coast will present “Sientra: The Newest Success Story in Santa Barbara’s Silicone Alley,” from 5 to 8 p.m. Wednesday, Jan. 16 at the Cabrillo Pavilion Arts Center, 1118 E. Cabrillo Blvd. in Santa Barbara.

Online pre-registration is now open. Click here to register online now to receive early-bird discount, available through Monday, Jan. 14. Walk-ins welcome at general admission rate.

The cost is $30 for online registration, or $40 at the door for general admission and $15 for students with ID. Note that the discounted early-bird registration is only applicable to those who register and pay online. No discount will apply to those who register online but choose to pay at door.

Payment methods accepted at door for general admission are cash, checks (made payable to MITEF-CC) and/or credit card (American Express, Visa, MasterCard, Discover).

Rocketing from obscurity to $151 million of investment and FDA approval, come hear founder and CEO Hani Zeini tell the Sientra story.

For many years, the breast implant business was dominated by two Santa Barbara-based companies — Inamed (now part of Allergan) and Mentor (now part of Johnson & Johnson). Following an unconventional path to introducing a new product, Sientra is disrupting the duopoly of breast implant titans.

Zeini will share his experience in launching a medical device company, his unique perspective on hiring and personnel, and the challenges of attracting investors.

Zeini has more than 24 years of relevant health-care experience in pharmaceuticals and medical device industries, and is an 11-year veteran in the aesthetics and plastic surgery market. He previously served as executive vice president of Inamed Aesthetics. He pioneered the concept of the Plastic Surgery Ecosystem™.

Zeini started his career at Dupont Pharmaceuticals, culminating with his role as senior vice president of Global Health Systems. Prior to joining Inamed, Zeini was COO at Acurian, a development stage venture capital backed clinical trials company. Before Acurian, he held the position of president and CEO at, an Internet-based health-care marketplace.

Zeini holds a bachelor’s degree in electrical and computer engineering from the University of Miami. In 2003, he completed the Stanford Executive Program at Stanford University, Graduate School of Business.

Michael Fauver of Buynak, Fauver, Archbald & Spray will serve as moderator.

Reader Comments

Noozhawk's intent is not to limit the discussion of our stories but to elevate it. Comments should be relevant and must be free of profanity and abusive language and attacks.

By posting on Noozhawk, you:

» Agree to be respectful. Noozhawk encourages intelligent and impassioned discussion and debate, but now has a zero-tolerance policy for those who cannot express their opinions in a civil manner.

» Agree not to use Noozhawk’s forums for personal attacks. This includes any sort of personal attack — including, but not limited to, the people in our stories, the journalists who create these stories, fellow readers who comment on our stories, or anyone else in our community.

» Agree not to post on Noozhawk any comments that can be construed as libelous, defamatory, obscene, profane, vulgar, harmful, threatening, tortious, harassing, abusive, hateful, sexist, racially or ethnically objectionable, or that are invasive of another’s privacy.

» Agree not to post in a manner than emulates, purports or pretends to be someone else. Under no circumstances are readers posting to Noozhawk to knowingly use the name or identity of another person, whether that is another reader on this site, a public figure, celebrity, elected official or fictitious character. This also means readers will not knowingly give out any personal information of other members of these forums.

» Agree not to solicit others. You agree you will not use Noozhawk’s forums to solicit and/or advertise for personal blogs and websites, without Noozhawk’s express written approval.

Noozhawk’s management and editors, in our sole discretion, retain the right to remove individual posts or to revoke the access privileges of anyone who we believe has violated any of these terms or any other term of this agreement; however, we are under no obligation to do so.

Support Noozhawk Today

You are an important ally in our mission to deliver clear, objective, high-quality professional news reporting for Santa Barbara, Goleta and the rest of Santa Barbara County. Join the Hawks Club today to help keep Noozhawk soaring.

We offer four membership levels: $5 a month, $10 a month, $25 a month or $1 a week. Payments can be made through PayPal below, or click here for information on recurring credit-card payments.

Thank you for your vital support.

Daily Noozhawk

Subscribe to Noozhawk's A.M. Report, our free e-Bulletin sent out every day at 4:15 a.m. with Noozhawk's top stories, hand-picked by the editors.

Sign Up Now >